Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Caris Life Sciences Inc., 1 year.
Caris Life Sciences Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Caris Life Sciences Inc. June 4, 202682.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | Caris Life Sciences Inc. | Grant or award | +13,192 | — | — |
| Aug 11, 2026 | Glaukos Corporation | Option exercise | +10,000 | $48.46 | $484,600 |
| Aug 11, 2026 | Glaukos Corporation | Option exercise | +20,000 | $55.18 | $1,103,600 |
| Aug 11, 2026 | Glaukos Corporation | Option exercise | +20,000 | $55.18 | $1,103,600 |
| Aug 11, 2026 | Glaukos Corporation | Option exercise | +10,000 | $48.46 | $484,600 |
| Aug 11, 2026 | Glaukos Corporation | Open-market sale | −27,963 | $178.89 | $5,002,301 |
| Aug 11, 2026 | Glaukos Corporation | Open-market sale | −32,037 | $180.49 | $5,782,358 |
| Jun 25, 2026 | Glaukos Corporation | Shares withheld for tax | −1,056 | $142.57 | $150,554 |
| May 1, 2026 | Glaukos Corporation | Open-market sale | −19,573 | $143.54 | $2,809,508 |
| Apr 2, 2026 | Glaukos Corporation | Shares withheld for tax | −3,169 | $109.60 | $347,322 |
| Mar 25, 2026 | Glaukos Corporation | Grant or award | +5,829 | — | — |
| Mar 25, 2026 | Glaukos Corporation | Grant or award | +17,792 | — | — |
| Mar 24, 2026 | Glaukos Corporation | Shares withheld for tax | −4,926 | $105.23 | $518,363 |
| Mar 24, 2026 | Glaukos Corporation | Shares withheld for tax | −7,388 | $105.23 | $777,439 |
| Mar 23, 2026 | Glaukos Corporation | Shares withheld for tax | −2,804 | $106.84 | $299,579 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.